{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:40:01Z","timestamp":1791308401324,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ejca.2006.11.016","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T07:07:29Z","timestamp":1170918449000},"page":"845-851","source":"Crossref","is-referenced-by-count":135,"title":["Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors"],"prefix":"10.1016","volume":"43","author":[{"given":"A.F.S.","family":"Galimont-Collen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.M.","family":"Lavrijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ouwerkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2006.11.016_bib1","first-page":"1S","article-title":"Targeting the epidermal growth factor receptor for cancer therapy","volume":"20","author":"Mendelsohn","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1523-1747.ep12259731","article-title":"Visualization of epidermal growth factor receptors in human epidermis","volume":"82","author":"Nanney","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/1523-1747.ep12276708","article-title":"Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition","volume":"85","author":"Green","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000247623","article-title":"Immunohistological expression of epidermal growth factor receptors in nuclei of a subpopulation of keratinocytes and sweat gland cells","volume":"183","author":"Pierard-Franchimont","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.ejca.2006.11.016_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/1523-1747.ep12874601","article-title":"Immunolocalization of epidermal growth factor receptors in normal developing human skin","volume":"94","author":"Nanney","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.7618084","article-title":"Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype","volume":"269","author":"Threadgill","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejca.2006.11.016_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","article-title":"Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225","volume":"144","author":"Busam","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2004.05.114","article-title":"Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor","volume":"22","author":"Vanhoefer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0093-7754(01)90283-0","article-title":"Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839","volume":"28","author":"Albanell","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/1523-1747.ep12340759","article-title":"EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation","volume":"109","author":"Peus","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","article-title":"Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation","volume":"163","author":"Mascia","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2006.11.016_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2004.06026.x","article-title":"Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours","volume":"151","author":"Jacot","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2230.2004.01466.x","article-title":"Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor","volume":"29","author":"Fernandez-Galar","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.2004.10.182","article-title":"Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor","volume":"22","author":"Saltz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2006.11.016_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.2005.04.057","article-title":"Practical management of patients with non-small-cell lung cancer treated with gefitinib","volume":"23","author":"Shah","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib17","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.2004.11.057","article-title":"Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer","volume":"22","author":"Perez-Soler","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.20.1.110","article-title":"Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition","volume":"20","author":"Albanell","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1610-0387.2005.05058.x","article-title":"The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies","volume":"3","author":"Segaert","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2006.11.016_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib21","first-page":"5919","article-title":"Abrogation of transforming growth factor-alpha\/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines","volume":"61","author":"Song","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2006.11.016_bib22","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1074\/jbc.M110897200","article-title":"Retinoids suppress epidermal growth factor associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1\/2 activation","volume":"277","author":"Sah","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2006.11.016_bib23","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1200\/JCO.2004.02.168","article-title":"Complications of therapy in cancer patients: case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer","volume":"22","author":"Chang","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib24","doi-asserted-by":"crossref","first-page":"26120","DOI":"10.1074\/jbc.M212082200","article-title":"Epidermal growth factor as a biologic switch in hair growth cycle","volume":"278","author":"Mak","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2006.11.016_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1126\/science.7618085","article-title":"Strain-dependent epithelial defects in mice lacking the EGF receptor","volume":"269","author":"Sibilia","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejca.2006.11.016_bib26","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1002\/j.1460-2075.1995.tb00206.x","article-title":"Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure","volume":"14","author":"Murillas","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2006.11.016_bib27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2004.06265.x","article-title":"Trichomegaly following treatment with gefitinib (ZD1839)","volume":"151","author":"Pascual","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02841860310006038","article-title":"Epidermal growth factor receptor inhibition induces trichomegaly","volume":"42","author":"Dueland","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2006.11.016_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2230.1986.tb00439.x","article-title":"Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects","volume":"11","author":"Baran","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2006.11.016_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000073100","article-title":"development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor","volume":"207","author":"Dainichi","year":"2003","journal-title":"Dermatology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906010288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906010288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T09:06:49Z","timestamp":1556096809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804906010288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0959804906010288"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2006.11.016","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}